Secretary's Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting, 46947-46948 [2010-19119]

Download as PDF 46947 Federal Register / Vol. 75, No. 149 / Wednesday, August 4, 2010 / Notices There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. Number of respondents/ participants per institution Number of institutions per year Number of responses per respondent Average burden hours per response Estimated total annual burden hours requested 20 40 4 13 20 8 2 2 2 2 2 2 1 1 1 1 1 1 1 2 1 1 1 1 40 160 8 26 40 16 Total .............................................................................. mstockstill on DSKH9S0YB1PROD with NOTICES Interviews with US-based principal investigators ................ Focus groups with selected trainees and follow-on survey Interviews with university leadership ................................... Interviews with trainees ....................................................... Interviews with foreign grantees .......................................... Interviews with foreign policy-makers/scientific leaders ...... 105 ........................ ........................ ........................ 290 Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Dr. Linda Kupfer, Fogarty International Center, National Institutes of Health, 16 Center Drive, Bethesda, MD 20892, or call non-toll-free number 301–496– 3288, or e-mail your request, including your address to: kupferl@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. VerDate Mar<15>2010 16:26 Aug 03, 2010 Jkt 220001 Dated: July 22, 2010. Timothy J. Tosten, Executive Officer, John E. Fogarty International Center, National Institutes of Health. [FR Doc. 2010–19160 Filed 8–3–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), notice is hereby given of the following meeting: Name: Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Dates and Times: September 16, 2010, 8:30 a.m. to 5 p.m., September 17, 2010, 8:30 a.m. to 3:30 p.m. Place: Marriott Washington at Metro Center, 775 12th Street, NW., Washington, DC 20005. Status: The meeting will be open to the public with attendance limited to space availability. Participants are asked to register for the meeting by going to the registration Web site at https://altarum.cvent.com/event/ achdnc2010. The registration deadline is Tuesday, September 14, 2010. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations should indicate their needs on the registration Web site. The deadline for special accommodation requests is Friday, September 10, 2010. If there are technical problems gaining access to the Web site, please contact Maureen Ball, Meetings Coordinator at conferences@altarum.org. Purpose: The Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (Advisory Committee) was established to advise and guide the Secretary regarding the most appropriate application of universal newborn PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. The Advisory Committee also provides advice and recommendations concerning the grants and projects authorized under the Public Health Service Act, 42 U.S.C. 300b–10, (Heritable Disorders Program) as amended in the Newborn Screening Saves Lives Act of 2008. Agenda: The meeting will include: (1) A presentation of the External Review Workgroup’s final report on the nomination of Critical Cyanotic Congenital Heart Disease and draft report on the nomination of Hyperbilirubinemia to the Advisory Committee’s recommended uniform screening panel; (2) a discussion of the Advisory Committee’s final draft of the report on the use and storage of newborn screening Residual Blood Spots; (3) an update on the report being developed by the Sickle Cell Disease Carrier Screening workgroup; and (4) presentations on the continued work and reports of the Advisory Committee’s subcommittees on laboratory standards and procedures, follow-up and treatment, and education and training. Proposed Agenda items are subject to change as priorities dictate. You can locate the Agenda, Committee Roster and Charter, presentations, and meeting materials at the home page of the Advisory Committee’s Web site at https://www.hrsa.gov/ heritabledisorderscommittee/. Public Comments: Members of the public can present oral comments during the public comment periods of the meeting, which are scheduled for both days of the meeting. Those individuals who want to make a comment are requested to register online by Tuesday, September 14, 2010 at https:// altarum.cvent.com/event/achdnc2010. Requests will contain the name, address, telephone number, and any professional or business affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The list of public comment participants will be posted on the Web site. Written comments should be emailed no later than Tuesday, September 14, 2010 for consideration. Comments should be submitted to Maureen Ball, Meetings E:\FR\FM\04AUN1.SGM 04AUN1 46948 Federal Register / Vol. 75, No. 149 / Wednesday, August 4, 2010 / Notices Coordinator, Conference and Meetings Management, Altarum Institute, 1200 18th Street, NW., Suite 700, Washington, DC 20036, telephone: (202) 828–5100, fax: (202) 785–3083, or e-mail: conferences@altarum.org. Contact Person: Anyone interested in obtaining other relevant information should contact Alaina M. Harris, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, telephone (301) 443–0721, aharris@hrsa.gov. More information on the Advisory Committee is available at https://mchb.hrsa.gov/ heritabledisorderscommittee. Dated: July 29, 2010. Sahira Rafiullah, Director, Division of Policy and Information Coordination. [FR Doc. 2010–19119 Filed 8–3–10; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–1578–N] Medicare Program; Listening Session Regarding Confidential Feedback Reports and the Implementation of a Value-Based Payment Modifier for Physicians, September 24, 2010 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. AGENCY: This notice announces a listening session being conducted as part of the transition to a value-based purchasing program for services of physicians and certain other professionals, as well as other related provisions under the Patient Protection and Affordable Care Act (known as the Affordable Care Act (ACA)). This public law contains provisions that continue and expand the Physician Feedback Program and also require implementation of a value-based payment modifier to the fee-for-service physician fee schedule. The purpose of the listening session is to solicit comments on approaches being considered as we implement these provisions. Physicians, physician associations, and all others interested in the use of confidential feedback reports as one means of enhancing quality and efficiency are invited to participate, in person or by calling in to the teleconference. The meeting is open to the public, but attendance is limited to space and teleconference lines available. Background information, including the mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:26 Aug 03, 2010 Jkt 220001 relevant preamble language from calendar year (CY) 2011 Physician Fee Schedule proposed rule will be posted on the CMS Web site at https:// www.cms.hhs.gov/center/physician.asp approximately 1 week prior to the session. DATES: Meeting Date: The listening session will be held on Friday, September 24th from 10 a.m. until 4 p.m. Eastern Daylight Time (e.d.t.) Deadline for Meeting Registration and Request for Special Accommodations: Registration opens on July 30, 2010. Registration must be completed by 5 p.m. e.d.t. on September 22, 2010. Requests for special accommodations must be received by 5 p.m. e.d.t. on September 22, 2010. Deadline for Submission of Written Comments or Statements: Written comments or statements may be sent via mail, fax, or electronically to the address specified in the ADDRESSES section of this notice and must be received by 5 p.m. e.d.t. on Monday, September 20, 2010. ADDRESSES: Meeting Location: The listening session will be held in the main auditorium of the Central Building of the Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, MD 21244–1850. Registration and Special Accommodations: Persons interested in attending the meeting or participating by teleconference must register by completing the on-line registration via the CMS Web site at https:// www.eventsvc.com/palmettogba/ 092410. Individuals who require special accommodations should send an e-mail request to pamela.cheetham@cms.hhs.gov or via regular mail to Pamela Cheetham at the address specified in the FOR FURTHER INFORMATION CONTACT section of this notice. Written Comments or Statements: Written comments or statements may be sent via e-mail to PhysicianVBP@cms.hhs.gov, faxed to 410–786–8005; or sent via regular mail to: Attn: Physician VBP Comments, Mail Stop C5–15–12, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, MD 21244–1850. All persons planning to make a statement in person at the listening session are urged to submit statements in writing at the listening session and should subsequently submit the information electronically by the timeframe specified in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: For further information regarding the September 24, 2010 listening session PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 contact Pamela Cheetham at (410) 786– 2259. You may also send inquiries about this listening session via e-mail to pamela.cheetham@cms.hhs.gov or via regular mail at Centers for Medicare & Medicaid Services, Mail Stop C5–15–12, 7500 Security Boulevard, Baltimore, MD 21244–1850. I. Background Section 131(c) of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) established the Physician Feedback Program that requires the Secretary to provide confidential feedback reports to physicians on resource use. Section 131(d) of MIPPA requires the Secretary to develop a plan for the transition to a value-based purchasing program for covered professional services. The Affordable Care Act contains several provisions related to implementation of physician valuebased purchasing (PVBP). Value-based purchasing is expected to create financial incentives for increasing quality of care and decreasing overall costs by transitioning to payment that will link levels of reimbursement to higher achievement of clinical quality and efficiency. Section 3003 of ACA continues and expands the Physician Feedback Program and requires the Secretary of Health and Human Services (the Secretary), beginning in 2012, to provide reports that compare patterns of resource use of individual physicians to other physicians. In addition, section 3007 of the ACA requires the Secretary to apply a budget-neutral payment modifier to the fee-for-service physician fee schedule beginning in 2015. During the listening session, we will discuss Phase I and Phase II of the Physician Feedback Program and outline the relevant sections of the ACA. Stakeholder input will be sought on a number of topics including but not limited to: report design and dissemination, cost and quality measures to assess performance, risk adjustment, attribution of Medicare beneficiaries to providers, benchmarking and peer groups, and composite measures of cost and quality. Background information, including the relevant preamble language from CY 2011 Physician Fee Schedule proposed rule (75 FR 40113 through 40116) will be posted on the CMS Web site at https://www.cms.hhs.gov/center/ physician.asp approximately 1 week prior to the session. The complete CY 2011 Physician Fee Schedule proposed rule appeared in the July 13, 2010, Federal Register (75 FR 40040) and is available at https://edocket.access. gpo.gov/2010/pdf/2010-15900.pdf. The E:\FR\FM\04AUN1.SGM 04AUN1

Agencies

[Federal Register Volume 75, Number 149 (Wednesday, August 4, 2010)]
[Notices]
[Pages 46947-46948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-19119]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Secretary's Advisory Committee on Heritable Disorders in Newborns 
and Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), notice is hereby given of the 
following meeting:

    Name: Secretary's Advisory Committee on Heritable Disorders in 
Newborns and Children.
    Dates and Times: September 16, 2010, 8:30 a.m. to 5 p.m., 
September 17, 2010, 8:30 a.m. to 3:30 p.m.
    Place: Marriott Washington at Metro Center, 775 12th Street, 
NW., Washington, DC 20005.
    Status: The meeting will be open to the public with attendance 
limited to space availability. Participants are asked to register 
for the meeting by going to the registration Web site at https://altarum.cvent.com/event/achdnc2010. The registration deadline is 
Tuesday, September 14, 2010. Individuals who need special 
assistance, such as sign language interpretation or other reasonable 
accommodations should indicate their needs on the registration Web 
site. The deadline for special accommodation requests is Friday, 
September 10, 2010. If there are technical problems gaining access 
to the Web site, please contact Maureen Ball, Meetings Coordinator 
at conferences@altarum.org.
    Purpose: The Secretary's Advisory Committee on Heritable 
Disorders in Newborns and Children (Advisory Committee) was 
established to advise and guide the Secretary regarding the most 
appropriate application of universal newborn screening tests, 
technologies, policies, guidelines and programs for effectively 
reducing morbidity and mortality in newborns and children having or 
at risk for heritable disorders. The Advisory Committee also 
provides advice and recommendations concerning the grants and 
projects authorized under the Public Health Service Act, 42 U.S.C. 
300b-10, (Heritable Disorders Program) as amended in the Newborn 
Screening Saves Lives Act of 2008.
    Agenda: The meeting will include: (1) A presentation of the 
External Review Workgroup's final report on the nomination of 
Critical Cyanotic Congenital Heart Disease and draft report on the 
nomination of Hyperbilirubinemia to the Advisory Committee's 
recommended uniform screening panel; (2) a discussion of the 
Advisory Committee's final draft of the report on the use and 
storage of newborn screening Residual Blood Spots; (3) an update on 
the report being developed by the Sickle Cell Disease Carrier 
Screening workgroup; and (4) presentations on the continued work and 
reports of the Advisory Committee's subcommittees on laboratory 
standards and procedures, follow-up and treatment, and education and 
training. Proposed Agenda items are subject to change as priorities 
dictate. You can locate the Agenda, Committee Roster and Charter, 
presentations, and meeting materials at the home page of the 
Advisory Committee's Web site at https://www.hrsa.gov/heritabledisorderscommittee/.
    Public Comments: Members of the public can present oral comments 
during the public comment periods of the meeting, which are 
scheduled for both days of the meeting. Those individuals who want 
to make a comment are requested to register online by Tuesday, 
September 14, 2010 at https://altarum.cvent.com/event/achdnc2010. 
Requests will contain the name, address, telephone number, and any 
professional or business affiliation of the person desiring to make 
an oral presentation. Groups having similar interests are requested 
to combine their comments and present them through a single 
representative. The list of public comment participants will be 
posted on the Web site. Written comments should be e-mailed no later 
than Tuesday, September 14, 2010 for consideration. Comments should 
be submitted to Maureen Ball, Meetings

[[Page 46948]]

Coordinator, Conference and Meetings Management, Altarum Institute, 
1200 18th Street, NW., Suite 700, Washington, DC 20036, telephone: 
(202) 828-5100, fax: (202) 785-3083, or e-mail: 
conferences@altarum.org.
    Contact Person: Anyone interested in obtaining other relevant 
information should contact Alaina M. Harris, Maternal and Child 
Health Bureau, Health Resources and Services Administration, Room 
18A-19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 
20857, telephone (301) 443-0721, aharris@hrsa.gov. More information 
on the Advisory Committee is available at https://mchb.hrsa.gov/heritabledisorderscommittee.

    Dated: July 29, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information Coordination.
[FR Doc. 2010-19119 Filed 8-3-10; 8:45 am]
BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.